anti-P2X7 monoclonal antibody humanized (Integral Molecular)

N/A

Report date: 2025/03/14 16:22:36

Base Information

Drug Nameanti-P2X7 monoclonal antibody humanized (Integral Molecular)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionP2X purinoceptor 7 modulators
TargetsP2X purinoceptor 7
Therapy Area/IndicationsAutoimmune DiseasesDermatitis, AtopicGlomerulonephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntegral Molecular Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntegral Molecular Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesDermatitis, AtopicGlomerulonephritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A